Heart, Lung, Blood and Sleep Disorders
Last data update: Jun 04, 2023 . (Total: 45418 Documents since 2020)
Records 1-30 (of 140 Records)
|Query Trace: Stroke[original query]|
| Stroke, Myocardial Infarction, and Pulmonary Embolism after Bivalent Booster.
Marie-Joelle Jabagi et al. N Engl J Med 2023 3 (15) 1431-1432
At 21 days after the booster dose, we found no evidence of an increased risk of cardiovascular events among the recipients of the bivalent vaccine as compared with recipients of the monovalent vaccine. The evaluated events included ischemic stroke (hazard ratio, 0.86; 95% confidence interval [CI], 0.58 to 1.27), hemorrhagic stroke (hazard ratio, 0.86; 95% CI, 0.46 to 1.61), myocardial infarction (hazard ratio, 0.92; 95% CI, 0.62 to 1.36), pulmonary embolism (hazard ratio, 0.83; 95% CI, 0.49 to 1.40), and all four events combined (hazard ratio, 0.87; 95% CI, 0.69 to 1.09).
| [Viral diseases of the nervous system-Selected new and old viruses].
Meyding-Lamadé Uta, et al. Der Nervenarzt 2023 0 0.
| Safety of COVID-19 Vaccines among Patients with Type 2 Diabetes Mellitus: Real-World Data Analysis.
Kim Hye Jun, et al. Diabetes & metabolism journal 2023 0 0.
| Psychological impact of COVID-19 containment on CADASIL patients.
Reyes S, et al. Journal of neurology 2023 0 0.
| The results of thrombectomy from the arteries of the lower extremities in patients infected with SARS-CoV-2 Omicron variant with different severity of respiratory failure.
Kazantsev Anton N, et al. Vascular 2023 0 0. 17085381231160933
| Characteristics of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.2 Subvariant in Jilin, China from March to May 2022.
Liu Han, et al. Journal of translational internal medicine 2023 0 0. (4) 349-358
| Neuropathological features of SARS-CoV-2 delta and omicron variants.
Normandin Erica, et al. Journal of neuropathology and experimental neurology 2023 0 0.
| Investigation of Neurological Complications after COVID-19 Vaccination: Report of the Clinical Scenarios and Review of the Literature.
Chen Wei-Ping, et al. Vaccines 2023 0 0. (2)
| Ischemic stroke after COVID-19 bivalent vaccine administration in patients aged 65 years and older: analysis of nation-wide patient electronic health records in the United States
M Gorenflo et al, MEDRXIV, February 14, 2023
| Epidemic of the SARS-CoV-2 Omicron Variant in Shanghai, China in 2022: Transient and Persistent Effects on Out-of-hospital Cardiac Arrests.
Li Guohui, et al. Resuscitation 2023 0 0. 109722
| Factors Associated with Stroke after COVID-19 Vaccination: A Statewide Analysis
F Nahab et al, MEDRXIV, February 9, 2023
The 21-day post vaccination incidence of ischemic stroke was 8.14, 11.14, and 10.48 per 100,000 for BNT162b2, mRNA-1273 and Ad26.COV2.S recipients, respectively. Concurrent COVID-19 infection had the strongest association with early ischemic and hemorrhagic stroke after first dose COVID-19 vaccination. The Ad26.COV2.S vaccine was associated with a higher risk of early post-vaccination ischemic stroke than BNT162b2.
| CDC & FDA Identify Preliminary COVID-19 Vaccine Safety Signal for Persons Aged 65 Years and Older
CDC, January 13, 2023
CDC’s Vaccine Safety Datalink (VSD) met the statistical criteria to prompt additional investigation into whether there was a safety concern for ischemic stroke in people ages 65 and older who received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent. Rapid-response investigation of the signal in the VSD raised a question of whether people 65 and older who have received the Pfizer-BioNTech COVID-19 Vaccine, Bivalent were more likely to have an ischemic stroke in the 21 days following vaccination compared with days 22-42 following vaccination.
| Population Risk Factors for Severe Disease and Mortality in COVID-19 in the United States during the Pre-Vaccine Era: A Retrospective Cohort Study of National Inpatient Sample.
Raj Kavin, et al. Medical sciences (Basel, Switzerland) 2022 0 0. (4)
| Hereditary thrombotic thrombocytopenic purpura and COVID-19: Impacts of vaccination and infection in this rare disease.
Tarasco Erika, et al. Research and practice in thrombosis and haemostasis 2022 0 0. (7) e12814
| Determinants of COVID-19 Outcome as Predictors of Delayed Healthcare Services among Adults ≥50 Years during the Pandemic: 2006-2020 Health and Retirement Study.
Beydoun Hind A, et al. International journal of environmental research and public health 2022 0 0. (19)
| The Effect of COVID-19 on the Perioperative Course of Acute Coronary Syndrome in Poland: The Estimation of Perioperative Prognosis and Neural Network Analysis in 243,515 Cases from 2020 to 2021.
Kaziród-Wolski Karol, et al. Journal of clinical medicine 2022 0 0. (18)
| miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections.
Kansakar Urna, et al. International journal of molecular sciences 2022 0 0. (18)
| Critical pediatric neurological illness associated with COVID-19 (Omicron BA.2.3.7 variant) infection in Taiwan: Immunological assessment and viral genome analysis in tertiary medical center.
Chen Chi-Sheng, et al. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2022 0 0.
| Genetic Predisposition to Severe COVID-19 Might Increase the Risk of Stroke: A Two-Sample Mendelian Randomization Study.
Zhang Jinji, et al. Frontiers in genetics 2022 0 0. 895211
| Neurological and psychiatric risk trajectories after SARS-CoV-2 infection: an analysis of 2-year retrospective cohort studies including 1 284 437 patients.
Taquet Maxime, et al. The lancet. Psychiatry 2022 0 0.
| Evaluation of urban green space per capita with new remote sensing and geographic information system techniques and the importance of urban green space during the COVID-19 pandemic.
Pouya Sima, et al. Environmental monitoring and assessment 2022 0 0. (9) 633
| Heart disease after COVID: what the data say
SM Sidik, Nature, August 2, 2022
Some studies suggest that the risk of cardiovascular problems, such as a heart attack or stroke, remains high even many months after a SARS-CoV-2 infection clears up. Researchers are starting to pin down the frequency of these issues and what is causing the damage.
| Deep Learning Paradigm for Cardiovascular Disease/Stroke Risk Stratification in Parkinson's Disease Affected by COVID-19: A Narrative Review.
Suri Jasjit S, et al. Diagnostics (Basel, Switzerland) 2022 0 0. (7)
| Risk stratification models for stroke in patients hospitalized with COVID-19 infection.
Merkler Alexander E, et al. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2022 0 0. (8) 106589
| Epidemiologic and Genomic Analysis of the Severe Acute Respiratory Syndrome Coronavirus 2 Epidemic in the Nebraska Region of the United States, March 2020-2021.
Siedlik Jacob A, et al. Frontiers in microbiology 2022 0 0. 878342
| Machine Learning and Lean Six Sigma to Assess How COVID-19 Has Changed the Patient Management of the Complex Operative Unit of Neurology and Stroke Unit: A Single Center Study.
Improta Giovanni, et al. International journal of environmental research and public health 2022 0 0. (9)
| Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies.
Luo Shan, et al. International journal of epidemiology 2022 0 0.
| Does COVID-19 increase the risk of neuropsychiatric sequelae? Evidence from a mendelian randomization approach.
Tirozzi Alfonsina, et al. World journal of psychiatry 2022 0 0. (3) 536-540
| Safety of SARS-CoV-2 vaccination in patients with Behcet's syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine.
Ozdede Ayse, et al. Rheumatology international 2022 0 0.
| Predictors of Covid-19 level of concern among older adults from the health and retirement study.
Beydoun Hind A, et al. Scientific reports 2022 0 0. (1) 4396
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: